NCT06699654

Brief Summary

This randomized controlled clinical study investigates the effectiveness of Spirulina gel and Spirulina nanoparticles gel in treating Stage II Grade B periodontitis. The research aims to compare the two formulations in terms of clinical, radiological, and biochemical outcomes, such as pocket depth reduction, alveolar bone density improvement, and inflammatory marker levels. The study seeks to provide insights into the potential of Spirulina-based therapies for enhancing periodontal health.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 21, 2024

Completed
3 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 24, 2024

Completed
23 days until next milestone

First Submitted

Initial submission to the registry

November 16, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 21, 2024

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2025

Completed
Last Updated

February 11, 2025

Status Verified

December 1, 2024

Enrollment Period

3 days

First QC Date

November 16, 2024

Last Update Submit

February 8, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Reduction in Probing Pocket Depth (PPD)

    The mean reduction in probing pocket depth in millimeters (mm) at periodontal sites treated with Spirulina gel and Spirulina nanoparticles gel.

    at baseline, 1 month , 3 months, 6 months

Secondary Outcomes (2)

  • Radiographic Bone Density Improvement

    at baseline and after 6 months

  • Biochemical Marker Levels

    Measured at baseline, 1 month ,3 months, and 6 months

Study Arms (3)

Group I (control group)

PLACEBO COMPARATOR

Participants in this arm will receive oral hygiene instruction and full mouth SRP of all teeth plus placebo gel instillation in the pocket.

Other: Placebo gel

Group II (experimental I)

ACTIVE COMPARATOR

Participants in this arm will receive oral hygiene instruction and full mouth SRP of all teeth followed by insertion of the spirulina gel instillation in the deepest selected periodontal pocket after drying the area around it.

Dietary Supplement: Spirulina Gel

Group III (experimental II)

EXPERIMENTAL

Participants in this arm will receive oral hygiene instruction and full mouth SRP of all teeth followed by insertion of the spirulina nanogel instillation in the deepest selected periodontal pocket after drying the area around it.

Dietary Supplement: Spirulina Nanoparticles Gel

Interventions

A gel without active Spirulina components applied as a control intervention.

Group I (control group)
Spirulina GelDIETARY_SUPPLEMENT

A conventional Spirulina gel formulation applied as a periodontal therapy.

Group II (experimental I)
Spirulina Nanoparticles GelDIETARY_SUPPLEMENT

A novel Spirulina nanoparticles gel formulation applied as a periodontal therapy.

Group III (experimental II)

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with good systemic health.
  • Patients who can maintain good oral hygiene.

You may not qualify if:

  • Any systemic disease that affects the periodontium. ·
  • Pregnant, postmenopausal women. ·
  • People who take anti-inflammatory drugs, antibiotics, or vitamins within the previous 3 month.
  • People who use mouth washes regularly ·
  • Participation in other clinical trials.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Doctor Mohamed Samir Periodontal and Implantology Clinic

El-Sheikh Zayed City, Cairo Governorate, 12573, Egypt

Location

MeSH Terms

Conditions

Periodontitis

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic Diseases

Study Officials

  • Enas Elgendy, Prof.Dr

    Kafrelsheikh University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants are randomly assigned to one of three arms: Spirulina Gel, Spirulina Nanoparticles Gel, or control. The interventions are administered over a defined period with radiological and biochemical assessments conducted at baseline and post-treatment.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
B.D.S. (2017) Misr University for Science and Technology

Study Record Dates

First Submitted

November 16, 2024

First Posted

November 21, 2024

Study Start

October 21, 2024

Primary Completion

October 24, 2024

Study Completion

May 1, 2025

Last Updated

February 11, 2025

Record last verified: 2024-12

Locations